DCOM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DCOM is a reasonable buy right now for a beginner-focused, long-term investor with $50,000-$100,000 to invest. The stock is not a momentum breakout, but it does show a constructive long-term setup with bullish moving averages, analyst price target increases, and improving earnings catalysts expected into 2026. At the current price of 37.04, it is near the lower end of the recent analyst target range and close to pivot resistance, so this is an acceptable entry for someone unwilling to wait for a perfect pullback. I would rate it a buy rather than a hold because the longer-term catalysts and analyst support outweigh the mixed short-term earnings picture.
Technically, DCOM is in a mildly bullish trend. The moving averages are aligned positively with SMA_5 above SMA_20 above SMA_200, which supports an upward trend structure. RSI_6 at 62.683 is neutral-to-bullish and does not indicate overbought conditions. MACD histogram is slightly negative at -0.027, suggesting short-term momentum is soft, but it is negatively contracting, which can signal weakening downside pressure. Price at 37.04 is just below R1 at 37.409 and above the pivot at 36.404, so the stock is sitting in a favorable short-term consolidation zone. The expected price behavior from similar candlestick patterns also points to modest upside over the next day, week, and month.
["DA Davidson raised its price target to $43 and reiterated Buy after Q1 results.", "Keefe Bruyette raised its price target to $43 and maintained Outperform.", "Piper Sandler initiated/assumed coverage with Overweight and a $37 target, supporting the current share price.", "Management is expected to benefit from stronger earnings growth in the second half of 2026 and into 2027.", "Catalysts include strong net interest margin, a shift toward lower-cost deposits, and a higher-yield loan mix.", "The company launched its Equipment & Franchise Finance Group, which could support future growth and diversification."]
["Latest quarter showed net income and EPS declining sharply year over year despite revenue growth.", "MACD is still slightly negative, indicating short-term momentum is not fully confirmed.", "Put-call open interest ratio is very high at 7.82, showing defensive options positioning.", "Hedge fund and insider trading trends are neutral, so there is no strong accumulation signal.", "The stock is trading just under near-term resistance around 37.41, limiting immediate upside."]
In the latest reported quarter, 2025/Q4, revenue rose sharply to 115.7 million, up 138.1% year over year, which is a strong top-line improvement. However, profitability weakened materially, with net income falling to 29.47 million and EPS dropping to 0.68, both down more than 225% year over year. This suggests the company is growing revenue, but earnings quality and margin durability need improvement. For a long-term investor, the important point is that analysts expect stronger earnings growth later in 2026 as balance sheet and loan-mix improvements continue.
Analyst sentiment is positive and improving. In late April 2026, DA Davidson raised the target to $43 from $39 and kept a Buy rating, citing stronger earnings growth ahead. Keefe Bruyette also lifted its target to $43 from $40 and maintained Outperform. Piper Sandler had earlier initiated coverage with an Overweight rating and a $37 target. The trend in ratings and targets is clearly upward, and Wall Street’s pro view is that NIM recovery, deposit transformation, and loan repricing will drive better earnings. The main con view is that recent reported earnings were weak despite revenue growth, so the near-term fundamentals are still uneven.
